Techno Ryowa Ltd. is a specialist in environmental control systems, offering services from initial design and construction through to ongoing maintenance, primarily within Japan. Its comprehensive industrial portfolio features cleanroom technologies, precision climate control, energy efficiency and resource recovery solutions, localized air conditioning, advanced industrial wastewater and air purification facilities, refrigeration and low-temperature equipment, production process optimization components, clean effluent processing plants, and equipment for nuclear power applications. Additionally, for general building applications, they supply vital infrastructure including standard air conditioning, plumbing networks, fire protection and disaster prevention systems, wastewater treatment installations, district cooling and heating solutions, and cogeneration power systems. Beyond installation, the company delivers comprehensive equipment maintenance, from diagnostic inspections to complete overhauls. They also undertake the design and construction of ancillary building systems and are involved in the manufacturing and distribution of associated machinery. Established in 1949, Techno Ryowa Ltd. is headquartered in Tokyo, Japan.

CEO

Masaya Kato

Employees

981

Country

Japan

ISIN

US05070R1041

Listings

0 Comments

Share your thoughts

FAQs

What is Audentes Therapeutics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Audentes Therapeutics stocks are traded under the ticker 22A.STU.

When is the next Audentes Therapeutics earnings date?▼

Audentes Therapeutics is going to release the next earnings report on November 9, 2026.

What were Audentes Therapeutics earnings last quarter?▼

22A.STU earnings for the last quarter are 0.18 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.

What is Audentes Therapeutics revenue for the last year?▼

Audentes Therapeutics revenue for the last year amounts to 550.1M EUR.

What is Audentes Therapeutics net income for the last year?▼

22A.STU net income for the last year is 65.56M EUR.

How many employees does Audentes Therapeutics have?▼

As of November 2, 2026, the company has 981 employees.

In which sector is Audentes Therapeutics located?▼

Audentes Therapeutics operates in the Manufacturing sector.

When did Audentes Therapeutics complete a stock split?▼

Audentes Therapeutics has not had any recent stock splits.

Where is Audentes Therapeutics headquartered?▼

Audentes Therapeutics is headquartered in Tokyo, Japan.